Final Trades: IBM, Moderna, GM & more
The “Halftime Report” traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV…
Read More »
Options traders order up Wendy’s calls
“Halftime Report” trader Pete Najarian spots unusual activity in the options market. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV for the…
Read More »
I don’t know if Apple earnings will be good this time, says Josh Brown
The investment committee joins the ‘Halftime Report’ to discuss what to expect from tech earnings this week. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn…
Read More »
We do still have a downside ahead of us, says Kindred Ventures’ Kanyi Maqubela
Kanyi Maqubela, Kindred Ventures, joins ‘TechCheck’ to discuss Tesla’s modest stock gain after the company’s earnings beat, what investors should do in today’s equity markets and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: …
Read More »
Top Five Things To Know In the Pakistani Stock Market on April 27, 2022
Brutal Attack on Chinese, Rolling Over of Future @ 13.50% and Expected Saudi Support will keep the Investor Sentiment divergent and biased towards long term investments in PAKISTAN
Read More »
Down 20% from peak to trough in the S&P is what you’re going to see, says The Satori Fund’s Niles
Dan Niles, the Satori Fund founder, joins ‘TechCheck’ to discuss how he is positioned ahead of earnings, what to expect from companies’ stock performance post-report and whether it’s time for the average investor to hold cash.
Read More »
MicroStrategy CEO offers Bitcoin in 401(k) plan
Michael Saylor, MicroStrategy CEO, joins ‘Squawk on the Street’ to discuss offering Bitcoin as an option in the company’s 401(k) plan.
Read More »
Novartis earnings edge higher in Q1, CEO breaks down quarter
Dr. Vas Narasimhan, Novartis CEO, joins ‘Squawk on the Street’ to discuss the company’s quarterly earnings results, Novartis’ upcoming pipeline and risks from the company’s exposure to China.
Read More »